Bipolar disorder trials in Ukraine
4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
- Where
- Dnipro, Hlevakha, Kropyvnytskyi, Odesa, Oleksandrivka, Poltava, Vinnytsia
- Age
- 18 years to 65 years
- People
- 274 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06951711 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
- Where
- Dnipro, Hlevakha, Kropyvnytskyi, Kyiv, Lviv, Odesa, Oleksandrivka, Poltava, Skarzhyntsi, Smila, Ternopil, Vinnytsia
- Age
- 18 years to 65 years
- People
- 424 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07140913 - Phase 3Taking peopleA Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
- Where
- Dnipro, Hlevakha, Kropyvnytskyi, Kyiv, Lviv, Odesa, Oleksandrivka, Poltava, Skarzhyntsi, Smila, Ternopil, Vinnytsia
- Age
- 18 years to 65 years
- People
- 450 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06929273 · EU 2024-520259-26-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
- Where
- Dnipro, Kropyvnytskyi, Kyiv, Poltava, Skarzhyntsi, Smila, Ternopil
- Age
- 18 years to 65 years
- People
- 274 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06951698